CCND2 and neoplasm: A recent study reported that BAP18 is upregulated in non–small cell lung carcinoma (NSCLC), particularly in advanced-stage tumors, and promotes tumor cell proliferation by enhancing the transcription of cell cycle–related genes, such as CCND1 (cyclin D1) and CCND2 (30).